menu
Research
Today's research for tomorrow's cure
Our Science
Research Groups
Facilities & Platforms
Clinical research
Find a researcher
Publications
Knowledge Transfer
Support us
Careers & study
Become a leader in cancer research
Vacancies
Faculty
Scientific staff
Scientific support staff
Postdoctoral fellows
PhD Students
Operational staff
Clinical fellows
Life in Amsterdam
Support us
News & Events
Check out our stories and backgrounds
News
Thematic collections
Media & Press
Calendar
Support us
About us
Maximum impact for cancer patients
Our vision
Organization
Collaborations
Responsible Research
Support us
Visit us
Contact us
Support us
Support us
Search
Support us
RESEARCH
PUBLICATIONS
AUTHOR CORRECTION: HIGH- OR LOW-DOSE PREOPERATIVE IPILIMUMAB PLUS NIVOLUMAB IN STAGE III UROTHELIAL CANCER: THE PHASE 1B NABUCCO TRIAL.
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Show more authors
+ 21
Jeroen van Dorp
Christodoulos Pipinikas
Britt B M Suelmann
Niven Mehra
Nick van Dijk
Giovanni Marsico
Maurits L van Montfoort
Sophie Hackinger
Linde M Braaf
Tauanne Amarante
Charlaine van Steenis
Kirsten McLay
Antonios Daletzakis
Daan van den Broek
Maaike W van de Kamp
Kees Hendricksen
Jeantine M de Feijter
Thierry N Boellaard
Richard P Meijer
Antoine G van der Heijden
Nitzan Rosenfeld
Bas W G van Rhijn
Greg Jones
Michiel S van der Heijden
More about this publication
Nature medicine
Volume 30
Issue nr. 1
Pages 304
Publication date 01-01-2024
Full text links
Publisher website (DOI)
10.1038/s41591-023-02500-7
Europe PubMed Central
37460757
Pubmed
37460757
Disclaimer
Privacy statement
Cookies
This site uses cookies
This website uses cookies to ensure you get the best experience on our website.